Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cell therapy
deals
diagnostics
drugs
immunotherapy
medicare
new england journal of medicine
nivolumab
novartis
What
drug
4
×
new
4
×
bio
roundup
advance
advantages
approval
approved
bar
biogen’s
biologic
biology
biopharmaceutical
brings
cancer
companies
convo
cytokine
deeper
demonstrating
diego’s
dna
drugs
earlier
enhanced
expect
failures
fda
fingerprint
gamble
genetic
going
lead
littered
market
matter
medco’s
medicine
mover
nash
Language
unset
Current search:
cancer
×
drug
×
new
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs